Ask anyone to identify Baltimore’s big anchors, and Under Armour and Johns Hopkins will likely appear in the same sentence.
Now the two are teaming up — brought together by tech.
The Accelerator Director serves as a principal member of the IPHA evaluation, selection and mentoring team responsible for the identification and development of new personalized health companies with the potential to produce disruptive technology solutions and achieve a high rate of growth.
The Accelerator Director is responsible for sourcing and conducting due diligence on IPHA applicants, evaluating and supporting new company formation strategies, mentoring entrepreneurs in personalized health product development, facilitating IPHA member network relationship development, maintaining board-level relationships and mentoring entrepreneurs in securing equity based capital for growth.
Additionally, the Director will support the growth and management of the IPHA mentor network whose participants provide guidance to portfolio companies. The Director will also work with members of the Inova Strategic Investment team to support the diligence process prior to subsequent investment transactions.
A half-dozen student-run startups at Johns Hopkins are getting some funding and help with developing their ideas.
Through the O’Connor Fund, the undergraduate student teams get a $5,000 grant plus access to mentors and other resources. There’s also an opportunity to receive another $5,000 if the teams reach specific business milestones. The program is run by Johns Hopkins Tech Ventures.
Massachusetts stole a second straight victory in Bloomberg’s ranking of the most innovative U.S. states, a testament to how much the economy’s wheels are greased by investment in higher education and research.
Venture capitalists invested $300 million in Maryland companies in 2016, a 70 percent drop from $1 billion the year before.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- NIH & AHRQ Update Font Guidelines for Applications to Due Dates On or After
- Technical Assistance Videocast for RFA RM-16-019 "NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)"
- Notice of Availability of Frequently Asked Questions and a Recording of the Pre-application Webinar on the NIH Illuminating the Druggable Genome (IDG) Program Website for RFA-RM-16-024, RFA-RM-16-025, and RFA-RM-16-026
Requests for Applications:
- National Centers for Cryoelectron Microscopy (U24)
- (RFA-RM-17-002)
- NIH Roadmap Initiatives
- Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Program Announcements:
- Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement
- (Admin Supp)
- (PA-17-101)
- Office of Research on Women's Health
- National Center for Advancing Translational Sciences
- National Eye Institute
- National Human Genome Research Institute
- National Heart, Lung, and Blood Institute
Under Armour Inc. CEO Kevin Plank's keynote speech Friday at the Consumer Electronics Show stressed the importance of product innovation and provided another clear sign that this is not your mom and pop’s CES anymore.
New East Baltimore Partnership ("FC-NEBP") and Toshiba Medical Research Institute USA, Inc. ("Toshiba Medical") announced today that they have executed a lease to construct a medical research center at 1812 Ashland Avenue, the newest building in the Science + Technology Park at Johns Hopkins. When it opens, the Toshiba Medical research center will showcase next-generation technology that will offer a unique opportunity at the Johns Hopkins East Baltimore Medical Campus to collaborate with researchers seeking the most advanced imaging capacity in the world.
Johnson & Johnson Innovation LLC, New York State and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in SoHo and will open in 2018. The project is receiving $17 million in New York State funding. The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A QuickFire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent, intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.
The DoD SBIR 17.1 & STTR 17.A Broad Agency Announcements are Now Open for Proposal Submission on January 10, 2017
You may now submit your Phase I and Direct to Phase II proposals for the open SBIR 17.1 and STTR 17.A Broad Agency Announcements (BAA) through the DOD SBIR/STTR proposal submission website at https://sbir.defensebusiness.org. All proposals for this Announcement must be received by 6:00 am. ET on Wednesday, February 8, 2017.
In the Obama administration’s final days, the National Cancer Institute is establishing an ambitious new program designed to allow scientists to more quickly access new drugs and compounds for novel research.
One of the last achievements of Vice President Joe Biden’s cancer moonshot initiative before he leaves office, the program was unveiled Wednesday and will begin as an agreement between the institute and six drug companies.
Geisinger Health System CEO Dr. David Feinberg used the StartUp Health Festival to launch its population health initiative, Springboard Health during the J.P. Morgan Healthcare Conference in San Francisco this week.
Prickly pear trees and the brown seaweed, commonly known as Peacocks tail, are a common sight in the Mediterranean. [Stephanie Ghio] It would seem that Juan Ponce de Leon’s trip to the New World in search of the fountain of youth may have been even more in vain, given that it may have been right in his “backyard.” Evidence from a new study by investigators at the University of Malta and the Centre National de la Recherche Scientifique (CNRS/University of Bordeaux) shows that chemicals in ubiquitous Mediterranean plants could hold the key to delaying age-related diseases.
Below is 450+ pages of our most popular research reports from last year. As always, if you find these reports helpful, share with friends. If you think they're terrible, please send to your enemies.
IBM Watson Health and Illumina have officially joined forces, announcing a new partnership on Monday as the J.P. Morgan Healthcare Conference kicks off.
Watson Health is a serial collaborator, but it chose a pivotal agreement to spotlight at JPM. By integrating with Illumina’s platform, the two companies can create an end-to-end tumor sequencing workflow that could increase accessibility and scalability in the field. It could also address a major problem, said Watson Health Vice President Steve Harvey; a lack of standardization.
From a brand new take on the electric breast pump to a discreet way to check sobriety during a night on the town, trust us, there's a lot of neat stuff on the horizon.
Tuesday, January 17, 2017, 10:30am - 12:00pm
Location:
UM BioPark, Life Sciences Conference Center
801 W. Baltimore Street
Baltimore Maryland 21201
Time: 10:30am to 12:00pm
Coffee Hour Seminar with Bob Dass, Ph.D., Field Applications Scientist Pall ForteBio
- Powerful Research Platform
- Antibody and Antibody Fragment Characterization
- Protein-protein and protein-peptide interactions
- Protein-DNA/RNA interactions
- Virus and vaccine research
- Protein-small molecule interactions
- Biotherapeutic Development/Biopharma Workhorse
- Cell line development
- Pharmacokinetics and pharmacodynamics
- Target identification and validation
- Lead identification
- RSVP to Mahasti Alavi
January 19, 2017 4pm - 8pm
Governor Calvert House
58 State Circle
Annapolis, Maryland
Maryland Health Information Management Systems Society (MDHIMSS) is pleased to announce our 10th Annual Advocacy event being held in Annapolis, Maryland on Thursday, January 19, 2016 at Governor Calvert House from 4-8pm. This event focuses on balancing the need for information exchange for Population Health and responsibility to protect and secure that information. In addition to legislative updates a panel discussion and technology showcase will be on display.
You will have the opportunity to meet and network with legislators from the House of Delegates, Senate and the Office of Governor Hogan during our evening event including hors d'oeuvre and cocktails.
Your legislators are very interested in hearing your suggestions to further improve our State's healthcare. This years' 90-day legislative session is set to have a fast start on Jan. 11th with numerous bills already being drafted for introduction; many that will impact healthcare. Join us in being a resource to our legislators by helping to further educate and provide resourceful information related to healthcare IT.
To attend you MUST REGISTER by January 16.
There is NO FEE for MDHIMSS Members. For Non-Members the fee of $60 covers admission plus a ONE YEAR free membership to MDHIMSS!
Thank you for your participation and we look forward to seeing you on January 19th.
